Top Urothelial Cancer Drugs Companies, Leaders & Major Players

This list of the top companies of Urothelial Cancer Drugs is drawn from assessments by Mordor Intelligence analysts and expert advisors via their extensive research to identify the brands, leaders and major players active in Urothelial Cancer Drugs sector.

Top Urothelial Cancer Drugs Companies

  1. Merck

  2. Bristol-Myers Squibb

  3. Novartis

  4. Roche

  5. AstraZeneca

*Disclaimer: Top companies sorted in no particular order

Urothelial Cancer Drugs Market Major Players

Urothelial Cancer Drugs - Competitive Concentration

Urothelial Cancer Drugs Market Concentration

List of Urothelial Cancer Drugs Companies

  • Merck

  • Roche

  • Bristol-Myers Squibb

  • AstraZeneca

  • Novartis

  • GlaxoSmithKline

  • Sanofi

  • Eisai

  • Astellas Pharma

  • UroGen Pharma Ltd.

  • Pfizer

  • Seagen

  • Johnson & Johnson (Janssen Biotech)

  • Gilead Sciences

  • ImmunityBio Inc.

  • CG Oncology

  • QED Therapeutics Inc.

  • BeiGene Ltd.

  • Mirati Therapeutics Inc.

Get more insights on Urothelial Cancer Drugs industry from our comprehensive report

Complete your form and get your market insights delivered to your inbox

Takes less than 10 seconds